Latest news with #HengruiPharmaceuticals
Bloomberg
22-05-2025
- Business
- Bloomberg
Top Chinese Drugmaker Hengrui Set to Begin Hong Kong Trading
Jiangsu Hengrui Pharmaceuticals Co., China's largest drugmaker by market value, is set to begin trading in Hong Kong Friday after raising HK$9.9 billion ($1.3 billion) as listings pick up in the Asian financial hub. The stock jumped in Hong Kong gray market trading on Thursday. The company had sold its stock at the top end of the marketed range amid strong demand for the shares.
Bloomberg
21-05-2025
- Business
- Bloomberg
Hengrui Pharma Prices at Top End for $1.3 Billion Hong Kong Listing
Jiangsu Hengrui Pharmaceuticals Co. priced its Hong Kong stock offering at the top of the marketed range to raise HK$9.9 billion ($1.3 billion). The Chinese drugmaker, which focuses its research on cancer and cardiovascular diseases, sold 224.5 million shares at HK$44.05 a share, according to terms of the deal seen by Bloomberg.
